Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
复制标题
DOI:
10.1136/annrheumdis-2014-205385
复制
发表时间:
2015-11
影响因子:
27.4
通讯作者:
Andrade F
中科院分区:
文献类型:
--
作者:
Konig MF;Paracha AS;Moni M;Bingham CO 3rd;Andrade F
Antibodies to citrullinated proteins (ACPAs) are a hallmark of rheumatoid arthritis (RA). Porphyromonas gingivalis peptidylarginine deiminase (PPAD) has been implicated in the initiation of RA by generating citrullinated neoantigens and due to its ability to autocitrullinate. To define the citrullination status and biology of PPAD in P gingivalis and to characterize the anti-PPAD antibody response in RA and associated periodontal disease (PD). PPAD in P gingivalis cells and culture supernatant was analyzed by immunoblotting and mass spectrometry to detect citrullination. Recombinant PPAD (rPPAD), inactive mutant PPAD (rPPADC351S), and N-terminal truncated PPAD (rPPADNtx) were cloned and expressed inE coli. Patients with RA and healthy controls were assayed for IgG antibodies to citrullinated rPPAD and unmodified rPPADC351S by ELISA. Anti-PPAD antibodies were correlated with anti-CCP3 antibody levels, RA disease activity, and PD status. PPAD from P gingivalis is truncated at the N- and C-terminal domains and not citrullinated. Only when artificially expressed in E coli, full-length rPPAD, but not truncated (fully active) rPPADNtx, is autocitrullinated. Anti-PPAD antibodies show no heightened reactivity to citrullinated rPPAD, but are exclusively directed against the unmodified enzyme. Antibodies against PPAD do not correlate with anti-CCP levels and disease activity in RA. By contrast, anti-PPAD antibody levels are significantly decreased in RA patients with PD. PPAD autocitrullination is not the underlying mechanism linking PD and RA. N-terminal processing protects PPAD from autocitrullination and enhances enzyme activity. Anti-PPAD antibodies may have a protective role for the development of PD in RA patients.
登录
查看更多内容
影响因子:
4.9
作者:
Arvikar SL;Collier DS;Fisher MC;Unizony S;Cohen GL;McHugh G;Kawai T;Strle K;Steere AC
通讯作者:
Steere AC
影响因子:
3.1
作者:
Kuboniwa, M;Amano, A;Hamada, S
通讯作者:
Hamada, S
影响因子:
3
作者:
NIEDERMAN, R;BRUNKHORST, B;RYDER, MI
通讯作者:
RYDER, MI
影响因子:
9.4
作者:
Griffen, AL;Lyons, SR;Leys, EJ
通讯作者:
Leys, EJ
影响因子:
3.1
作者:
Gibson, FC;Genco, CA
通讯作者:
Genco, CA